Daniel L. Alkon is President and CSO of Synaptogenix Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Synaptogenix, Inc.
20 Dec 22
4/A
Synaptogenix, Inc.
1 Dec 22
4/A
Synaptogenix, Inc.
1 Dec 22
4
Synaptogenix, Inc.
17 Nov 22
4
Synaptogenix, Inc.
15 Jul 21
4
Synaptogenix, Inc.
16 Jun 21
3
Synaptogenix, Inc.
14 Jun 21
4
Neurotrope, Inc.
3 Dec 20
4
Neurotrope, Inc.
27 Nov 20
4
Neurotrope, Inc.
24 Jan 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Dec 22 | SNPX Synaptogenix | Common Stock, par value $0.0001 per share | Sell | Dispose S | No | Yes | 1.1719 | 19,688 | 23.07 k | 35,546 |